Company Monitoring Page for Biogen

latest headlines for company on cafepharma

Eisai and Biogen’s latest Alzheimer’s drug needs to be cheaper than the last one, analysts say
Stat
Thu, 12/22/22 - 11:10 am
Tags:
Biogen, Eisai, Alzheimer's disease, drug pricing, ICER, lecanemab
3rd patient death potentially tied to Eisai's Alzheimer's drug reported
Fierce Biotech
Thu, 12/22/22 - 11:05 am
Tags:
Biogen, Eisai, Alzheimer's disease, clinical trials, patient deaths, lecanemab
Ahead of lecanemab decision, Alzheimer's groups petition CMS to reverse coverage policy
Endpoints
Wed, 12/21/22 - 11:31 am
Tags:
Biogen, FDA, Alzheimer's disease, CMS, clinical trials
Roche takes over development of Biogen-partnered lymphoma drug
BioPharma Dive
Tue, 12/20/22 - 11:11 am
Tags:
Roche, Biogen, lymphoma, glofitamab
Biogen's ALS Drug Tofersen Filing Accepted in Europe
Zacks.com
Tue, 12/6/22 - 10:48 am
Tags:
Biogen, ALS, EMA, Europe, tofersen
Lilly’s Donanemab Shines vs. Aduhelm in First Active Comparator Study
BioSpace
Thu, 12/1/22 - 07:10 pm
Tags:
Eli Lilly, donanemab, clinical trials, Aduhelm, Biogen, Alzheimer's disease
CTAD 2022 – lecanemab data hold up, with a big but
EP Vantage
Thu, 12/1/22 - 07:01 pm
Tags:
Biogen, Eisai, Alzheimer's disease, CTAD, lecanemab, clinical trials
Go or no go? Mirati heads to the FDA
EP Vantage
Wed, 11/30/22 - 10:34 am
Tags:
FDA, Mirati Therapeutics, Gilead Sciences, Coherus Biosciences, Roche, Biogen, TG Therapeutics, Ipsen, Novartis, BeiGene, Cytokinetics
What to make of Eisai and Biogen’s latest Alzheimer’s drug data
BioPharma Dive
Tue, 11/29/22 - 10:58 pm
Tags:
Biogen, Eisai, Alzheimer's disease, lecanemab
Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal
Fierce Biotech
Mon, 11/28/22 - 07:51 pm
Tags:
Biogen, Eisai, clinical trials, patient death, lecanemab, Alzheimer's disease
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Wed, 11/16/22 - 10:45 am
Tags:
Roche, Alzheimer's disease, gantenerumab, Biogen, Cassava Sciences, Eli Lilly
Biogen appoints ex-Sanofi chief Christopher Viehbacher as CEO
Medical Marketing and Media
Thu, 11/10/22 - 10:51 am
Tags:
Biogen, Pharma CEOs, Christopher Viehbacher, Chris Viehbacher
J&J vet Mammen wanted board influence to be Biogen's next CEO, but chairman said no
Fierce Pharma
Tue, 11/8/22 - 10:43 pm
Tags:
JNJ, Biogen, Pharma CEOs, Mathai Mammen
Biogen, BioAge and PTC Present Novel MoAs in Neurodegenerative Diseases
BioSpace
Mon, 11/7/22 - 10:52 am
Tags:
neurodegenerative disease, Biogen, BioAge Labs, PTC Therapeutics
MS Drug Advances from Merck, BMS and More Showcased at ECTRIMS Conference
BioSpace
Wed, 10/26/22 - 06:51 pm
Tags:
Merck, Biogen, Bristol Myers Squibb, MS, multiple sclerosis, ECTRIMS
Biogen's Q3 revenue declines 10% as focus shifts to new Alzheimer's and ALS drug candidates
Endpoints
Tue, 10/25/22 - 11:05 am
Tags:
Biogen, earnings, Alzheimer's disease, ALS, tofersen, lecanemab
Where Will Biogen Be in 5 Years?
Motley Fool
Thu, 10/20/22 - 10:39 am
Tags:
Biogen, Aduhelm, lecanemab, Alzheimer's disease, M&A
Biogen's ALS ambitions on pause as FDA delays approval decision by 3 months
Fierce Biotech
Mon, 10/17/22 - 10:53 am
Tags:
Biogen, tofersen, FDA, ALS
Sage, Biogen post fresh phase 3 depression data as FDA filing nears completion
Fierce Biotech
Mon, 10/17/22 - 10:39 am
Tags:
SAGE Therapeutics, Biogen, zuranolone, postpartum depression, clinical trials
4 Biotech Stocks With Huge Incoming Catalysts
Motley Fool
Wed, 10/12/22 - 11:03 am
Tags:
FDA, Biogen, Eisai, Alzheimer's disease, Gilead Sciences, HIV, Mirati Therapeutics, lung cancer, lecanemab, lenacapavir, adagrasib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.